Elekta AB ADR | |
Stock Exchange | Other OTC |
EPS |
$0.34 |
Market Cap |
$5.2 B |
Shares Outstanding |
368.59 M |
Public Float |
- |
Elekta AB Series B | |
Stock Exchange | Other OTC |
EPS |
$0.34 |
Market Cap |
$5.41 B |
Shares Outstanding |
368.59 M |
Public Float |
- |
Elekta AB Series B | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
368.59 M |
Public Float |
- |
Elekta AB Series B | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK3.13 |
Market Cap |
SEK51.08 B |
Shares Outstanding |
368.59 M |
Public Float |
358 M |
Address |
Kungstensgatan 18 Stockholm SD 103 93 Sweden |
Employees | - |
Website | http://www.elekta.com |
Updated | 07/08/2019 |
Elekta AB engages in the provision of clinical solutions for the treatment of cancers and brain disorders. Its products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America; Europe. |